Results 71 to 80 of about 1,185 (135)

An Equity‐Focused Systematic Analysis of Antimicrobial Resistance National Action Plans in 14 West African Countries

Tropical Medicine &International Health, Volume 30, Issue 12, Page 1295-1312, December 2025.
ABSTRACT Objectives Antimicrobial resistance is a growing global health threat that disproportionately affects socially and economically disadvantaged populations. National Action Plans are critical for coordinating national responses, but the extent to which they address equity remains unclear. This study assessed how antimicrobial resistance National
Yusuff Adebayo Adebisi, Isaac Olushola Ogunkola, Adeola Bamisaiye, Aminat Olaitan Adebayo, Noah Sesay, Kwasi Yelarge, Don Eliseo Lucero‐Prisno III   +6 more
wiley   +1 more source

The Substandard and falsified medicines in the Democratic Republic of the Congo: Situational analysis and future perspectives

Orapuh Journal
Introduction The circulation of counterfeit medicines in the Democratic Republic of the Congo (DRC) and elsewhere is driven by several factors, including regulatory weaknesses, inadequate inspections, and porous borders.
Michel NTAMBWE NGOYI, Donatien KABAMB KABEYA, Didi Mana Kialengila, Roland Marini Djang’ieng’a, Jéremie Mbinze Kindenge   +4 more
doaj   +1 more source

Fighting the fakes: tackling substandard and falsified medicines

Nature Reviews Disease Primers, 2022
Pyzik, Oksana Zirka, Abubakar, Ibrahim
openaire   +3 more sources

Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries

Globalization and Health, 2018
Background The spread of substandard and falsified (SF) medical products constitutes a growing global public health concern. Some countries use portable, handheld screening technologies (STs) in the field to accelerate detection of SF medicines and ...
Lukas Roth, Ameena Nalim, Beth Turesson, Laura Krech   +3 more
doaj   +1 more source

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community

Journal of Pharmaceutical Policy and Practice, 2020
Background Medical products are an integral and pivotal part of health care delivery. They need to be available, affordable and quality-assured. The SADC region is prone to threats arising from the availability and use of substandard and falsified (SF ...
Stanislav Kniazkov, Sakhile Dube-Mwedzi, Jean-Baptiste Nikiema   +2 more
doaj   +1 more source

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems

Globalization and Health, 2018
Access to quality-assured medical products improves health and save lives. However, one third of the world’s population lacks timely access to quality-assured medicines while estimates indicate that at least 10% of medicine in low- and middle-income ...
Lukas Roth, Daniel Bempong, Joseph B. Babigumira, Shabir Banoo, Emer Cooke, David Jeffreys, Lombe Kasonde, Hubert G. M. Leufkens, John C. W. Lim, Murray Lumpkin, Gugu Mahlangu, Rosanna W. Peeling, Helen Rees, Margareth Ndomondo-Sigonda, Andy Stergachis, Mike Ward, Jude Nwokike   +16 more
doaj   +1 more source

Patients Access to Medicines – A Critical Review of the Healthcare System in Kenya

Risk Management and Healthcare Policy, 2022
Anthony Martin Toroitich,1,2 Louise Dunford,3 Rachel Armitage,4 Sangeeta Tanna2 1Trade Affairs Department, Pharmacy and Poisons Board, Nairobi, Kenya; 2Leicester School of Pharmacy, De Montfort University, Leicester, UK; 3Leicester School of Allied ...
Toroitich AM, Dunford L, Armitage R, Tanna S   +3 more
doaj  

Assessing ethical practices among community pharmacists in Nigeria: prevalence, drivers, challenges, and implications—a mixed methods study

Frontiers in Public Health
IntroductionGiven the accessibility of community pharmacists as the first point of care in Nigeria and their expanding role in optimizing public health, it is critical that they employ evidence-based, ethical practices.
Olanrewaju Olamide Popoola, Olanrewaju Olamide Popoola, Igbagboyemi Adebowale Adebisi, Igbagboyemi Adebowale Adebisi, Adebowale Sylvester Adeyemi, Damilola Samson Adepitan, Damilola Samson Adepitan, Opeyemi Fortunate Oladeru, Opeyemi Fortunate Oladeru   +8 more
doaj   +1 more source

Quality improvement in medicines regulation: a retrospective analysis of the Pharmacy Board of Sierra Leone before and during quality management system implementation

BMC Health Services Research
Background National Medicines Regulatory Authorities like the Pharmacy Board of Sierra Leone are responsible for protecting and promoting public health, implementing regulatory standards, and maintaining a supply chain with an assured supply of medical ...
Michael Lahai, Laurie Lake, Ahmed Vandy, Bondu Sebba, Mohamed Sesay, Onome T. Abiri, Joy Johnson, Tamba Buffa, Abdulai Kanu, Mohamed Bawoh, James P. Komeh, Wiltshire C.N Johnson   +11 more
doaj   +1 more source

Health, Economic, and Social Impacts of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review of Methodological Approaches. [PDF]

Am J Trop Med Hyg, 2023
Salami RK, Valente de Almeida S, Gheorghe A, Njenga S, Silva W, Hauck K.   +5 more
europepmc   +1 more source